Commercializing Successful Biomedical Technologies
Seiten
2022
|
2nd Revised edition
Cambridge University Press (Verlag)
978-1-316-51006-3 (ISBN)
Cambridge University Press (Verlag)
978-1-316-51006-3 (ISBN)
Transform your ideas into commercial biomedical products, and start your own business, with this updated second edition. Containing over 25% brand new material, this book combines real-world case studies with industry tips to walk you step-by-step through the process of commercialization.
Transform your research into commercial biomedical products with this revised and updated second edition. Covering drugs, devices and diagnostics, this book provides a step-by-step introduction to the process of commercialization, and will allow you to create a realistic business plan to develop your ideas into approved biomedical technologies. This new edition includes: Over 25% new material, including practical tips on startup creation from experienced entrepreneurs. Tools for starting, growing and managing a new venture, including business planning and commercial strategy, pitching investors, and managing operations. Global real-world case studies, including emerging technologies such as regulated medical software and Artificial Intelligence (AI), offer insights into key challenges and help illustrate complex points. Tips and operational tools from established industry insiders, suitable for graduate students and new biomedical entrepreneurs.
Transform your research into commercial biomedical products with this revised and updated second edition. Covering drugs, devices and diagnostics, this book provides a step-by-step introduction to the process of commercialization, and will allow you to create a realistic business plan to develop your ideas into approved biomedical technologies. This new edition includes: Over 25% new material, including practical tips on startup creation from experienced entrepreneurs. Tools for starting, growing and managing a new venture, including business planning and commercial strategy, pitching investors, and managing operations. Global real-world case studies, including emerging technologies such as regulated medical software and Artificial Intelligence (AI), offer insights into key challenges and help illustrate complex points. Tips and operational tools from established industry insiders, suitable for graduate students and new biomedical entrepreneurs.
Shreefal Mehta is Executive Chair of Pulmokine Inc, Entrepreneur in Residence at the Lally Center for Technological Entrepreneurship, Rensselaer Polytechnic Institute, and Visiting Faculty at Center of Advanced Studies on Entrepreneurship in BioMedicine (CASE BioMed) Universita Svizzeria Itialia.
1. The biomedical device and drug industry and their markets learning points; 2. Markets of interest and market research steps learning points; 3. Starting up your company; 4. Intellectual property and licensing; 5. New product development (NPD); 6. The regulated market: gateway through the FDA learning points; 7. Manufacturing; 8. Reimbursement, marketing, sales, and product liability learning points.
| Erscheinungsdatum | 08.11.2022 |
|---|---|
| Zusatzinfo | Worked examples or Exercises |
| Verlagsort | Cambridge |
| Sprache | englisch |
| Maße | 176 x 250 mm |
| Gewicht | 960 g |
| Themenwelt | Medizin / Pharmazie ► Physiotherapie / Ergotherapie ► Orthopädie |
| Technik ► Medizintechnik | |
| Technik ► Umwelttechnik / Biotechnologie | |
| ISBN-10 | 1-316-51006-9 / 1316510069 |
| ISBN-13 | 978-1-316-51006-3 / 9781316510063 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Spiraldynamik - programmierte Therapie für konkrete Resultate
Buch | Hardcover (2021)
Thieme (Verlag)
CHF 146,95
